Pulborough-based Arun Veterinary Group has been awarded the title of Best UK Vets, having achieved the largest number of positive online reviews on www.vethelpdirect.com.
The awards are based on the number of positive reviews (4 stars and above) left by owners on the site over the course of the year, with owners asked to review the practice on five key areas: respect for my animal, professionalism, friendliness, cleanliness and value for money.
Comments attached to the 182 reviews for Arun included: "Nothing is too much trouble", "Fabulous vets" and "More like good friends."
Vet Help Direct said: "A good online reputation is so valuable to both local people looking for a service and to business owners. That's why online vet reviews are at the heart of our vet directories. Vet Help Direct is determined to provide a fair reflection of the vet practices in their online directories; all reviews are subject to rigorous tests of authenticity, all are checked for duplicate IP addresses, email addresses and some reviewers are asked to provide evidence that they are recent clients of the practice."
In second place was St Georges Veterinary Group, Wolverhampton, which is now up to 132 reviews and in third place was Goddard Veterinary Group, Gidea Park in London, with 122 reviews.
Pfizer Animal Health is offering the chance to win £500 worth of CPD vouchers to UK veterinary surgeons who participate in the company's 5 minute online survey about Equine Herpes Virus (EHV).
Pfizer says the intention of the survey is to find out more about veterinary perceptions and understanding of this endemic disease and its effects on the UK's valuable equine industry. There are five multi-choice questions and the survey is available online from now until 31st May 2012. Vets who show their prowess in the skills-based section of the survey will be entered to win £500 of British Equine Veterinary Association CPD vouchers.
The survey is part of Pfizer's EHV awareness campaign to help vets encourage horse owners, yard managers, trainers and breeders to keep their horses protected from the effects of this common but often under-prioritised disease. The campaign includes the provision of information leaflets and the coordination of talks to help people, who manage horses, understand the severity of EHV and the best ways to prevent it.
According to Pfizer, the prevalence of EHV can be as high as 87.5% in the UK and latent infections in horses are frequently re-activated.1,2 The consequences can be serious, with abortion outbreaks proving to be a significant economic burden to owners, trainers and breeders.3,4 However, subclinical infections, although usually regarded as less serious, can remain unrecognised and can cause suboptimal performance in horses.
Sporadic, mild respiratory disease caused by EHV can lead to interrupted training and movement restrictions.4 Even after clinical recovery from EHV-1 or upper respiratory tract infections caused by EHV-4, some horse may develop 'poor performance syndrome'.5 These can all have serious financial repercussions on the equine industry.
To take part in the survey, visit http://www.ehvaware.com/. For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients please contact your Pfizer Account Manager.
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142. 2. Allen GP. 2002. Respiratory Infections by Equine Herpesvirus Types 1 and 4. In: P. Lekeux ed. 2002. Equine Respiratory Diseases. New York: International Veterinary Information Service. 3. Garré B et al. Vet Microbiol. 2007; 122(1-2): 43-51. 4. Lunn DP et al. J Vet Intern Med. 2009; 23(3): 450-61. 5. Slater, J. 2007. Equine Herpesvirus. In: Sellon, D. and Long, M. Equine Infectious Diseases. St Louis: Saunders. 144.
Firstly, pets that haven’t received primary vaccinations due to the coronavirus outbreak and develop an issue that would have been prevented by a vaccination they were unable to access, will now have that condition covered under their Agria policy.
Secondly, the company has now made it possible for owners of cats and dogs under the age of five to set up a 'Four Weeks Free' policy - which would ordinarily be set up in practice - themselves.
Simon Wheeler, Managing Director of Agria Pet Insurance (pictured right), said: "We have introduced these additional products during the pandemic to ensure that pets remain covered despite new and significant challenges faced by vets and owners. We hope that they alleviate a little of the pressure faced by veterinary staff and worry felt by owners."
Robin Hargreaves, who is Agria's Vet Lead and helped develop the solutions said: "Times are pretty tough in practice right now, and operating on a restricted basis isn’t ideal for us or the pets registered with us. One thing that would make life even harder would be if the percentage of uninsured pets was to rise.
"With Agria making it possible for owners to activate their own 4 Weeks Free policies at this time, even owners that can’t see vets as usual can still protect their pets with insurance.
“Relaxing restrictions around cover for unvaccinated pets will come as a huge relief in some cases, enabling any pets that have missed primary vaccinations or gone past their booster date due to current restrictions to still be insured."
For more information, visit: agriapet.co.uk/guide
The company points to an increasing trend across Europe towards feeding raw diets to pets, with 4% of UK cats and 10% of UK dogs now being fed raw meat and animal by-products.
The webinar, which will also look at the role of testing, offers an opportunity to learn more about the pathogens and parasites associated with raw feeding and the role of the right test at the right time.
Horiba says it's not just pets that need testing, but the raw materials used in their food.
Ian, who is Head of ESCCAP (the European Scientific Council for Companion Animal Parasites) UK & Ireland, said: “The recent trend of increasing raw feeding opens up new opportunities for pathogen transmission.
"Where raw feeding is taking place, adequate tapeworm and protozoal parasite prevention is essential to reduce zoonotic risk and economic losses.
“Testing forms an essential part of their control, and understanding this role and the diagnostic test options available will prove valuable to all veterinary professionals.”
Following Ian's presentation, there will be an open Q&A session.
Horiba’s team of veterinary specialists will also be available at the end of the webinar to discuss and advise on any testing needs, including its veterinary PCR system, the POCKIT Central.
To register, visit: https://register.gotowebinar.com/register/4306408134214190348
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
Henry Schein Inc. has announced an agreement to acquire RxWorks Inc., the veterinary practice management software provider.
Founded in 1988 and with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 team members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide (primarily Australia, New Zealand, the UK and the Netherlands).
Henry Schein says RxWorks will become part of it's Global Animal Health Practice Solutions business, led by its current management team.
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. said: "RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions.
"The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."
Nathan Basha, Chairman of RxWorks said: "RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients. Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."
Henry Schein says it expects the acquisition to close in the second half of January 2016. Financial details and terms of the transaction were not disclosed.
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
Husky, a rather aptly named refrigeration company, has announced it is to launch a veterinary vaccine fridge.
According to the company, the new fridge is a specially adapted version of its SS1 model, one of the most popular refridgerators for caterers because of its performance, reliability and durability.
The new unit is designed to ensure the safe storage of a wide range of vaccines at 2º - 8º degrees Celsius. The unit also incorporates an audible door open alarm, failed temperature alarm, and a fail-safe secondary back-up digital display thermometer as an added safeguard.The vaccine refrigerator door includes security lock as standard, and the refrigerant used in manufacture is R600, a highly efficient hydrocarbon refrigerant coolant - CFC-free and a natural non-greenhouse gas.
Geoff Thomasson, Chief Executive of the Husky team of companies said: "The SS1 has long been a winner with the hospitality trade and we believe we will enjoy similar success with this medical version. The potential market is enormous."
For more information, ring 01455 555340 or email: info@husky-global.com
Heath Vets, a Cardiff-based veterinary group, has announced that is has become the first veterinary group in Wales to appoint designated customer care personnel, enabling it to take on and beat the corporates at customer service.
Leanne Kiddie was appointed Customer Care Manager, tasked with ensuring the group delivers excellent customer service across its four sites, after the veterinary group identified customer service as their key driver to retaining customers, attracting new customers and sustaining growth.
Gavin Hill-John (pictured right with Leanne), Operations Director at Heath Vets said: "We want to put our customers at the forefront of our service. The traditional veterinary practice model was based around territory; you had one vet practice in an area and local people used it. They weren’t challenged on customer service as we are today. Having Leanne as our dedicated Customer Care Manager will help us set Heath Vets apart from other practices. Whilst we may not be able to compete with the buying power of some national chains, we can certainly beat them at customer service."
Heath Vets says it is now developing its engagement with customers regarding future plans; using their comments and feedback to shape the practice.
Gavin added: "We are aiming to deliver a level of engagement with our customers that no other vet practice has seen before. We’re hosting cheese and wine functions where customers can come in, enjoy our festive hospitality, and speak with the staff about their pet’s issues. We not only want to work with our customers, but we want to get to know them."
Gavin says he believes Heath Vets can challenge all competitors when it comes to customer service: "My vision for the role is that across all four sites we should be delivering outstanding customer service, consistently. To achieve that aim, everybody needs to be highly skilled, trained, motivated and engaged. For us, it’s about recognising that we have a hugely impressive team that are focussed on delivering high quality customer service. National chains have investors and shareholders to please; we have our customers."
In order to prevent tail injury in one dog you'd need to dock 500, according to research published in this week's Veterinary Record.The study1 was based on 138,212 dogs seen by vets at 52 veterinary practices across Britain between March 2008 and March 2009. 281 were treated for a tail injury - a rate of 0.23%, adjusted for sampling. The owners of 224 of these injured dogs, as well as a random sample of 799 owners whose dogs had not been treated for tail injury were sent a questionnaire on dog tail injuries and docking.Only 97 of the owners whose dogs needed treatment and 227 of those whose dogs had not been injured replied.Their responses indicated that around one in three tail injuries (36%; 35 cases) had occurred at home as a result of the dog knocking its tail against a wall, kennel wall or other household object.A further 17.5% (17 cases) were sustained outdoors, while 14.4% (14 cases) were caused by the tail being caught in a door. In 15 (15.5%) other causes were cited; and in 16 (16.5%), the cause was unknown. Almost half of the injuries (44%) were recurrent.Over half the cases were treated with drugs and dressings, but in almost one in three cases, amputation was required. Eleven dogs did not need any treatment.Certain breeds seemed to be more at risk, with springer and cocker spaniels almost six times as likely to sustain a tail injury as labradors and retrievers. Greyhounds, lurchers, and whippets were almost seven times as likely to do so, possibly because of the lack of protective hair on their tails, say the authors. Dogs with a wide angle of wag were also almost four times as likely to be injured in this way, while dogs kept in kennels were more than 3.5 times as likely to sustain a tail injury. Only 35 owners said their dogs had had their tail docked, and on the basis of their overall findings, the authors calculated that tail docking would reduce the risk of injury by 12%.But in absolute terms, 500 dogs would need to have their tail docked in order to prevent one tail injury.
Reference1Risk factors for tail injuries in dogs in Great Britain. G. Diesel, D. Pfeiffer, S. Crispin, and D. Brodbelt. The Veterinary Record 2010 166: 812-817.
Tatiana graduated from the University of Trás-os-Montes e Alto Douro, Portugal in 2005.
She worked for more than 10 years in general practice in Portugal, where she dedicated most of her time to dermatology.
She started a three-year residency in 2016 at the at the Hospital Clinic Veterinari of the Fundació Universitat Autònoma de Barcelona and became a diplomate of the ECVD in 2020.
Tatiana’s appointment means NDSR will now offer a specialist-led dermatology service five days a week.
Tatiana said: “I am so excited to be a part of such an amazing multi-disciplinary hospital like NDSR.
“It’s not often that you come across hospitals which have all the equipment and services at hand to provide expert diagnosis to animals quickly and efficiently.
“My mission is to build on NDSR’s excellent service to primary care vets and pet owners in the region and hope that we can continue to act as a real extension of their teams.”
Gerry Polton, clinical director at NDSR, said: “Tatiana is clearly a very experienced and respected dermatologist and we are so pleased she has joined NDSR."
For more information, visit www.ndsr.co.uk/home.
The VetCT teleconsulting service, which can be accessed via the web and an app-based platform, provides advice from a specialist team.
Typically advice is provided as a written report within 24 hours, with options for text chat or telephone conversations when vets may want to discuss the case with a specialist.
The service can be accessed on a pay-per-case or subscription basis.
Until now, follow-up advice had been capped at two weeks.
Internal medicine specialist and Head of Teleconsulting at VetCT, Kate Murphy, said: “We are delighted to be extending our support for cases that require ongoing management, such as endocrine disorders or complex wound management.
"Our clients have fed back how valuable it will be to partner with us longer term for these patients, to provide guidance and reassurance that care is being optimised and help to keep owners engaged and happy.”
welcome.vet-ct.com/sales
CEVA Animal Health has introduced Carprodyl® F, a new flavoured version of Carprodyl®.
The company says that the original version of Carprodyl®, the carprofen-based painkiller, has proved very popular with vets, partly thanks to its cost-effective pricing and special offers which help to maximise practice profitability. Carprodyl® F is still priced to boost practice profits, but is now packed with additional improvements.
Palatability is known to be an important factor when it comes to owner compliance. Carprodyl® F contains new pork and yeast flavouring, which has been shown to be extremely appetising for dogs. In CEVA's palatability studies, 100% of dogs took the flavoured tablets voluntarily from the hand or in food. In addition Carprodyl® F is now available in a new 100mg tablet size, which makes dosing easier and more cost-effective for the owners of large dogs.
For further product information and details on how Carprodyl® F can benefit your clients and improve practice profits, please contact your local CEVA representative or call the veterinary support team on 01494 781510, CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
Dan Forster MRCVS and his wife Kirsty, a veterinary nurse, run The Mobile Vet Ltd, which offers a 24/7 mobile service to clients and their animals on the Isle of Wight. The team work out of custom-designed vehicles, as well as their fully equipped static veterinary clinic in Newport.
In launching The Mobile Vet, their vision was to create a mobile clinic which could provide all of the services normally provided in a traditional clinic rather than just some. The veterinary team uses the latest technology and veterinary software to communicate with clients and works from vehicles specifically designed by Dan and Kirsty.
The Queen’s Awards for Enterprise are awarded to businesses for outstanding achievement in International Trade, Innovation and Sustainable Development. Winners of the Innovation Awards are judged to have shown outstanding success as the result of an innovation.
Dan said: "We aim to offer a caring and professional service to Islanders and their pets while also maintaining a good work/life balance. We can do almost everything from our vehicles but, when necessary, we utilise our fully equipped static clinic. We aim to offer a highly professional veterinary service using state-of-the-art equipment, which is also convenient to our clients. We have recently introduced a CT scanning service and laparoscopic surgery to expand our clinical services further.
"We are honoured to receive this prestigious award and had a fantastic day. The Award would never have been achievable without the support of our wonderful team. We look forward to continuing to provide an exemplary level of service to our clients."
Bayer Animal Health has launched Back to Basics, a new guide to antibiotic use which focuses on the concerns raised by vets and vet students about antibiotics in a survey carried out by the company.
465 vets and 40 students took part in the survey in March 2014. Of these:
27% of vets admitted that they struggle to know which antibiotic is the most appropriate for a specific condition. This uncertainty was particularly the case if the patient is un-responsive to the vet's first choice antibiotic, or the condition develops to require a new or additional antibiotic choice. Bayer says it is also clear that many vets may not be aware that pradofloxacin is the least likely of the veterinary fluoroquinolones to select for antibiotic resistance,2 as 23% of vet students and 9% of vets said they believe that all antibiotics carry the same risk of selecting for resistance.
The company says Back to Basics is designed to fill the gaps in knowledge identified by the survey. It presents each of the major classes of veterinary antibiotic and details how they work. It also includes an antibiotics 'jargon buster' to help vets and vet students better understand the commonly used measures of antibiotic activity and make more informed decisions about the use of antibiotics in practice.
Bayer has also developed an online self-assessment quiz that allows vets and students to check their knowledge. The quiz and the guide are both available at www.veraflox.co.uk
References
An animal heath company is conducting a survey into veterinary surgeons' thoughts on digestive health conditions, including diarrhoea.
Everyone who participates in the survey will be entered into a prize draw to win £100 worth of John Lewis vouchers.
To take part, visit https://www.surveymonkey.com/s/digestive-health-survey.
The survey will remain live till 28th March 2014, and the results will be shared with participants in due course.
According to a survey of 2,000 dog owners by Burgess Supadog Sensitive, 18% of women say they speak to their dog more than their partner or husband.
Not only that, but it seems the older you are, the more likely you are to strike up a conversation with the dog: 21 per cent of respondents aged 45-54 said they talked to their dog more than their partner as opposed to 10 per cent of 18-24 year olds.
Other findings from the survey included:
Lanes Health, manufacturer of the mobility supplement, LitoVet, has announced the nominees for the inaugural Litovet Equine Scientific Achievement Award, part of the annual Animal Health Trust (AHT) awards.
The award which has been set up to recognise a person or group whose clinical or scientific work has made a substantial difference to the equine veterinary world will be judged by a panel of leading veterinary surgeons and scientists.
The nominees are:
Peter Clegg - MA VerMB PhD CertsES DepEVCS MRCVS. Dr Clegg is Professor of Equine Surgery and Deputy Head of the Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, The University of Liverpool. Peter's current research focus is equine orthopaedics, in particular identifying the basic mechanisms of injury and repair in equine joints and tendons. He has supervised 13 successful PhD students and is currently supervising a further nine.
Andy Durham BSc, BVSc, DEIM, Dipl.ECEIM, MRCVS (RCVS & European Specialist in equine internal medicine). Liphook-based Andy Durham exemplifies the premise that veterinarians in practice can maintain an active interest in current research, undertake clinically relevant research projects, interact with researchers on an international stage and contribute to CPD through scientific papers, book chapters and lectures.
Tim Mair BVSc PhD DEIM DESTS DipECEIM MRCVS. Dr Mair ha been innovative in veterinary practice (e.g., an early adopter of standing magnetic resonance imaging [MRI]), has an extensive publication list recently focusing on evidence-based medicine for colic, but spanning the full breadth of common medical disorders in horses. He has made an enormous contribution to veterinary practice within both Europe and America in his role as Editor of Equine Veterinary Education.
Chris Proudman MA VetMB PhD CertEO FRCVS.Dr Proudman is Professor of Equine Studies at the University of Liverpool. His research interests are related to the aetiology and surgical management of acute intestinal disease (colic) in the horse: specifically, the diagnosis of intestinal parasites associated with colic and understanding dietary determinants of colic. Most recently this has involved using metabolomics and molecular microbiology to investigating the intestinal microbiota and its response to dietary change.
The LitoVet Equine Scientific Achievement Award can be granted to any individual or group that is currently undertaking, or has successfully implemented within the past ten years, one or more clinical or other research projects which has, or will, make a significant contribution to equine health and welfare.
The award will be presented to the recipient, or recipients, at the UK Equestrian Awards held at the Lancaster London on Thursday 3 November 2011.
The Royal Veterinary College has opened a new specialist ophthalmologist service at the Queen Mother Hospital for Animals (QMHA) in Hertfordshire.
According to the College, the service is equipped with the most up-to-date and state-of-the-art equipment available and will also benefit from the on-hand support of leading edge veterinary care at Europe's largest small animal hospital.
The RVC says all ophthalmology cases will be supported by dedicated anesthesiologists, whilst on an individual case basis the ophthalmologists will draw upon the expertise of specialists in imaging, oncology, neurology, emergency and critical care, internal medicine, dermatology, soft tissue and orthopedic surgery.
The following services will be available to all species on referral:
Rick F. Sanchez, who heads up the new service, holds a Diploma from the European College of Veterinary Ophthalmologists (DipECVO) and is currently the only Ophthalmology Diploma holder working in a UK university. In his new role Rick will be sharing his expertise gained from the 3 years intensive specialist training and 7 years in dedicated specialty practice with both undergraduate and postgraduate students at the college in a teaching role alongside his clinical and research responsibilities.
Rick said: "Returning to academia has been the realization of a long held professional dream and to do so by becoming part of the Royal Veterinary College has been a privilege and an honour. The superb team of specialists and dedicated nurses already established at the RVC creates a perfect environment to exercise clinical excellence and offer our animal patients the very best care we strive to provide as specialists.
"In addition, I see the creation of the new Ophthalmology Service as the final piece of the puzzle within the wide array of clinical expertise offered at QMHA. In my opinion it is this wide array of expertise that makes the QMHA at the RVC a leading centre for clinical, teaching and research excellence in veterinary medicine in the UK."
For more information please visit: http://www.rvc.ac.uk/QMH/Specialities/Ophthalmology.cfm
The RCVS has announced a number of senior staff changes.
Gordon Hockey has been ratified by Council as Head of Legal Services and Registrar. This is a new role created when the post of Registrar and Secretary was split into two: Chief Executive and Secretary; and Head of Legal Services and Registrar.
Gordon, who was previously Assistant Registrar/Head of Professional Conduct, and then Acting Registrar, will have oversight responsibility for registration and professional conduct.
At the same time, Eleanor Ferguson, formerly Acting Head of Professional Conduct, has been confirmed in the position.
The post of Head of Registration has been made redundant, with a new role of Customer Experience Manager created to ensure that the customer (public and profession) journey improves across the organisation. This position will also report into Gordon Hockey.
There have been other changes on the Senior Team at the College. The post of Head of Corporate Services that had been vacant since the departure of Richard Holford last December will not be filled, and Head of Finance Corrie McCann has been promoted to the new role of Head of Operations, which will incorporate finance, corporate services (IT, mailing, reception) and facilities.
Two other posts have been made redundant: Special Projects Manager and RCVS Charitable Trust Director. A new post of Executive Director for the Trust will be developed, with a view to taking the Trust through a full strategic review.
Chief Executive Nick Stace said: "I believe that an engaged and well-purposed team of staff, with a focus on customer service and driving improvements, lies at the heart of any successful organisation. These changes will enable the College to move into the next stage of its development towards becoming a first-rate regulator."
The changes will mean that the Senior Team is reduced from 11 people to seven, being the Chief Executive plus Heads of Legal Services, Operations, Human Resources, Education, Veterinary Nursing and Communications.
The RCVS and the BVA have published the Vet Futures report: their vision for how the veterinary profession should look in 2030, coupled with 34 recommendations for change.
The report, which represents the culmination of a year of engagement, consultation and research with the veterinary profession, veterinary nurses, members of the wider veterinary team, key stakeholders, animal owners and the general public, says that in 2030 vets should be a leading force for animal health and welfare and valued for their wider roles in society. They should be confident, resilient, healthy and well supported, and benefit from exceptional leadership. And there should be a broad range of diverse and rewarding veterinary careers, as well as thriving, innovative and user-focused businesses.
While the focus of Vet Futures has been on veterinary surgeons, Vet Futures engaged with the RCVS Veterinary Nurses Council and British Veterinary Nursing Association, as well as individual veterinary nurses, and the College says that many of the ambitions should resonate with members of both professions. It goes on to recommend that the veterinary nursing profession should build on the work of Vet Futures to develop its own clear vision and ambitions.
The recommendations within the report include:
Other recommendations include developing an animal welfare strategy for the profession, increasing collaboration with medical professionals and environmental organisations, adopting a more strategic long-term outlook for research funding, and exploring how to encourage a more diverse profession.
RCVS President Bradley Viner said: "The Vet Futures report is the culmination of a year of research and engagement with thousands of members of the veterinary and veterinary nursing professions, which has given us a very firm foundation on which to build our ambitions and recommendations. We are extremely grateful to every individual who has contributed in some way to the project, and helped us to seize the initiative.
"Over the years the veterinary profession has proved itself to be adaptable and able to face challenges head on, and we have no doubt that by working together we will realise our joint vision of a profession in charge of its future. Ultimately, we all want a profession that is confident in itself and one in which members are proud to call themselves veterinary surgeons."
Sean Wensley, BVA President, added: "Vet Futures has proved to be an exciting, engaging and truly ambitious project for the veterinary profession and it has created a fantastic level of debate and engagement.
"The report we are launching today is not the end of the story; it is the beginning of the next chapter. It is crucial that we maintain the momentum of the project so we will be inviting members of the veterinary professions to step forward and join a new Vet Futures Action Group to help us turn the recommendations into actions and drive forward activity."
The full report can be downloaded here.
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”